People

Tracy Bahl

Tracy Bahl is a Managing Director of Valtruis and an Operating Partner at WCAS, having joined in 2021 focusing on healthcare investments. He was formerly the President and Chief Executive Officer of OneOncology, a company dedicated to serving all those living with cancer through a network of leading community oncology practices across the U.S. Prior to OneOncology, Tracy served as Executive Vice President of Health Plans for CVS Health; Executive Chairman of Emdeon, an industry leading healthcare information and transaction services company; Special Advisor at General Atlantic; Chief Executive Officer of Uniprise, a UnitedHealth Group Company; and held various executive positions at CIGNA HealthCare. Tracy earned MBA degrees from Columbia University and the London Business School as well as a Bachelor of Arts degree from Gustavus Adolphus College. Tracy Bahl is publicly named in Despierta’s combined advisors and select limited partners roster. The source does not distinguish this individual’s advisory or LP capacity, identify a commitment amount, or supply a substantive biography; its generic image and placeholder biography are excluded. The affiliation is recorded with this explicit limitation.

Roles

Valtruis

Managing Director

Current
Despierta Ventures

Advisor / Select LP (specific capacity undisclosed)

Current